Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-196319

Chief Development Officer sold 20,000 shares at an average $70.49 ($1,409,848)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2025-09-02 Option exercise 10b5-1 +20,000 $21.65 $433,000 25,487 D: show line 1 in the form
Guyer William Chief Development Officer 2025-09-02 Sale 10b5-1 −15,594 $70.39 $1,097,693 9,893 D: show line 2 in the form
Guyer William Chief Development Officer 2025-09-02 Sale 10b5-1 −4,406 $70.85 $312,155 5,487 D: show line 3 in the form
Open-market sales · 20,000 sh · avg $70.49 · $1,409,848

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2025-09-02 Option exercise · Stock option (right to buy) 10b5-1 −20,000 330,000 D: show line 4 in the form
Loading xslF345X05/ownership.xml…